2019 Q4 Form 10-Q Financial Statement

#000143774919022502 Filed on November 12, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q4
Revenue $3.916M $454.0K $1.767M
YoY Change 121.62% 61.57% -34.56%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.330M $1.460M $1.230M
YoY Change 8.13% -12.57% -147.31%
% of Gross Profit
Research & Development $3.290M $3.713M $4.470M
YoY Change -26.4% -15.25% 78.8%
% of Gross Profit
Depreciation & Amortization $750.0K $131.0K $820.0K
YoY Change -8.54% 0.77% 115.79%
% of Gross Profit
Operating Expenses $9.542M $5.168M $5.953M
YoY Change 60.29% -16.12% 138.12%
Operating Profit -$4.714M
YoY Change -19.83%
Interest Expense $30.00K $84.00K -$160.0K
YoY Change -118.75% -34.88%
% of Operating Profit
Other Income/Expense, Net -$510.0K -$515.0K -$560.0K
YoY Change -8.93% -22.9% 40.0%
Pretax Income -$6.210M -$5.229M -$4.820M
YoY Change 28.84% -20.14% 46.06%
Income Tax $200.0K $31.00K $80.00K
% Of Pretax Income
Net Earnings -$6.409M -$5.260M -$4.902M
YoY Change 30.74% -19.67% 44.18%
Net Earnings / Revenue -163.66% -1158.59% -277.42%
Basic Earnings Per Share -$0.69
Diluted Earnings Per Share -$133.5K -$323.7K -$0.69
COMMON SHARES
Basic Shares Outstanding 47.72M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.50M $19.60M $11.50M
YoY Change 17.39% 9.5% 283.33%
Cash & Equivalents $13.53M $19.60M $11.51M
Short-Term Investments $0.00
Other Short-Term Assets $500.0K $1.100M $1.300M
YoY Change -61.54% 10.0% 1200.0%
Inventory
Prepaid Expenses
Receivables $3.619M $559.0K $1.796M
Other Receivables $0.00 $0.00 $1.800M
Total Short-Term Assets $17.60M $21.25M $14.65M
YoY Change 20.16% 10.7% -54.8%
LONG-TERM ASSETS
Property, Plant & Equipment $210.0K $1.469M $1.066M
YoY Change -80.3% 33.55% 433.0%
Goodwill
YoY Change
Intangibles $17.09M $17.53M $19.41M
YoY Change -11.95%
Long-Term Investments
YoY Change
Other Assets $141.0K $145.0K $103.0K
YoY Change 36.89%
Total Long-Term Assets $19.43M $21.44M $20.58M
YoY Change -5.58% 0.19% 10191.0%
TOTAL ASSETS
Total Short-Term Assets $17.60M $21.25M $14.65M
Total Long-Term Assets $19.43M $21.44M $20.58M
Total Assets $37.03M $42.70M $35.23M
YoY Change 5.12% 5.16% 8.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $852.0K $1.049M $962.0K
YoY Change -11.43% -19.31% -43.41%
Accrued Expenses $4.565M $1.603M $1.518M
YoY Change 200.72% 0.19% -39.28%
Deferred Revenue $110.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00 $2.500M $1.700M
YoY Change -100.0% 47.06% 13.33%
Total Short-Term Liabilities $9.174M $9.154M $7.475M
YoY Change 22.73% 14.43% 31.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $1.900M
YoY Change -100.0% -100.0% -95.09%
Other Long-Term Liabilities $18.00K $18.00K $157.0K
YoY Change -88.54% -99.87% 57.0%
Total Long-Term Liabilities $18.00K $18.00K $157.0K
YoY Change -88.54% -99.89% 57.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.174M $9.154M $7.475M
Total Long-Term Liabilities $18.00K $18.00K $157.0K
Total Liabilities $24.08M $23.79M $23.99M
YoY Change 0.38% -3.28% 10.04%
SHAREHOLDERS EQUITY
Retained Earnings -$116.7M -$110.3M -$97.99M
YoY Change 19.06% -43.19%
Common Stock $129.6M $129.2M $109.2M
YoY Change 18.66% -33.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.95M $18.90M $11.21M
YoY Change
Total Liabilities & Shareholders Equity $37.03M $42.70M $35.23M
YoY Change 5.12% 5.16% 8.06%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q4
OPERATING ACTIVITIES
Net Income -$6.409M -$5.260M -$4.902M
YoY Change 30.74% -19.67% 44.18%
Depreciation, Depletion And Amortization $750.0K $131.0K $820.0K
YoY Change -8.54% 0.77% 115.79%
Cash From Operating Activities -$3.790M -$4.330M -$5.700M
YoY Change -33.51% -19.22% 2.89%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$130.0K -$200.0K
YoY Change -95.0% -23.53% 66.67%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$10.00K -$130.0K -$200.0K
YoY Change -95.0% -23.53% -93.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.230M 7.760M -520.0K
YoY Change 328.85% -1751.06% -2700.0%
NET CHANGE
Cash From Operating Activities -3.790M -4.330M -5.700M
Cash From Investing Activities -10.00K -130.0K -200.0K
Cash From Financing Activities -2.230M 7.760M -520.0K
Net Change In Cash -6.030M 3.300M -6.420M
YoY Change -6.07% -155.0% -26.54%
FREE CASH FLOW
Cash From Operating Activities -$3.790M -$4.330M -$5.700M
Capital Expenditures -$10.00K -$130.0K -$200.0K
Free Cash Flow -$3.780M -$4.200M -$5.500M
YoY Change -31.27% -19.08% 1.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Small Business
EntitySmallBusiness
true
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Type
DocumentType
10-Q
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47722895
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
Vaxart, Inc.
dei Entity Shell Company
EntityShellCompany
false
dei Trading Symbol
TradingSymbol
vxrt
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1049000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
962000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
559000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1796000
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1603000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1518000
CY2019Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
35000
dei Entity Central Index Key
EntityCentralIndexKey
0000072444
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Security12b Title
Security12bTitle
Common Stock, $0.10 par value
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Cash
Cash
11441000
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
166000
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1956000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1570000
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
124533000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
108513000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
146000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
490000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
183000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
387000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
560000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
70000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
146000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
183000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
490000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
387000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
18000
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
433000
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
812000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1887000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2030000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15030424
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
989409
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9807084
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1363016
CY2019Q3 us-gaap Assets
Assets
42695000
CY2018Q4 us-gaap Assets
Assets
35227000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
21254000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
14645000
us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
6660000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1929000
CY2019Q3 us-gaap Cash
Cash
19543000
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
25525000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19600000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19558000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11506000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1571000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17922000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8052000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16351000
CY2019Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
45401562
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
47614992
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1099454
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46223594
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7141189
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46223594
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7141189
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
4622000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
714000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Concentration of Credit Risk</div>&nbsp;&#x2013;&nbsp;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. The Company places its cash, cash equivalents and short-term investments at financial institutions that management believes are of high credit quality. The Company is exposed to credit risk in the event of default by the financial institutions holding the cash and cash equivalents to the extent such amounts are in excess of the federally insured limits. The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any losses on its deposits since inception.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The primary focus of the Company&#x2019;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#x2019;s investment policy addresses the level of credit exposure by limiting the concentration in any <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>&nbsp;corporate issuer or sector and establishing a minimum allowable credit rating. The Company generally requires <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> collateral from its customers.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2019Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
204000
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
110000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
CY2018Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
0.22148
CY2018Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-27000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
35577000
CY2019Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
111000
CY2019Q3 us-gaap Depreciation
Depreciation
131000
CY2018Q3 us-gaap Depreciation
Depreciation
130000
us-gaap Depreciation
Depreciation
386000
us-gaap Depreciation
Depreciation
349000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2854000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2379000
us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.92
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.96
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.23
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1027000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
632000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y222D
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1100000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
70000
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
67000
CY2018Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4654000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2767000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
10166000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
433000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1731000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1732000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1732000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1732000
CY2019Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
22180000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
22180000
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17526000
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
11000
CY2018Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-18000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-164000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
416000
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17526000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19413000
CY2019Q3 us-gaap Interest Expense
InterestExpense
84000
CY2018Q3 us-gaap Interest Expense
InterestExpense
129000
us-gaap Interest Expense
InterestExpense
288000
us-gaap Interest Expense
InterestExpense
702000
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
58000
CY2018Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
11000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
97000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
52000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-32000
us-gaap Interest Paid Net
InterestPaidNet
195000
us-gaap Interest Paid Net
InterestPaidNet
276000
CY2019Q3 us-gaap Lease Cost
LeaseCost
253000
us-gaap Lease Cost
LeaseCost
684000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-215000
CY2018Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Thereafter
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter
CY2018Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within One Year
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear
213000
CY2018Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Three Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears
38000
CY2018Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Two Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears
219000
CY2019Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
CY2018Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
us-gaap Gain Loss On Investments
GainLossOnInvestments
us-gaap Gain Loss On Investments
GainLossOnInvestments
-3000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1455000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1674000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4856000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5455000
CY2019Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
CY2018Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
1600000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5229000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6548000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11942000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-13076000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
294000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
136000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3495000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1237000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15040000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-449000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6391000
us-gaap Net Income Loss
NetIncomeLoss
-13105000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5260000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6548000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12236000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3074000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
482000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
348000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
336000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
620000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1024000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
264000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
560000
CY2019Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2019Q3 us-gaap Liabilities
Liabilities
23792000
CY2018Q4 us-gaap Liabilities
Liabilities
23989000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42695000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35227000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9154000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7475000
CY2019Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
15000
CY2018Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
15000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18188000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1210000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-838000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
26407000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9298000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8846000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-5260000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-6548000
us-gaap Net Income Loss
NetIncomeLoss
-12236000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13105000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5260000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6548000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-12236000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13444000
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
3000
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
102000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-515000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-668000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1783000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4494000
CY2019Q3 us-gaap Notes Payable
NotesPayable
2500000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
5168000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
6161000
us-gaap Operating Expenses
OperatingExpenses
16105000
us-gaap Operating Expenses
OperatingExpenses
19962000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4714000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5880000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10159000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17570000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2514000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
258000
us-gaap Operating Lease Cost
OperatingLeaseCost
703000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1083000
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3425000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2636000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
820000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1694000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
253000
us-gaap Operating Lease Payments
OperatingLeasePayments
740000
CY2018Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
255000
us-gaap Operating Lease Payments
OperatingLeasePayments
623000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2301000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1053
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y299D
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1326000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
859000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
470000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
56000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
411000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
246000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
195000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
145000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
157000
us-gaap Other Noncash Expense
OtherNoncashExpense
93000
us-gaap Other Noncash Expense
OtherNoncashExpense
408000
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
320000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
21000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
573000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
838000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
512000
CY2019Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
CY2018Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
339000
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1137000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1343000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2500000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2540000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
1988000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
1250000
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
1111000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1469000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1066000
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
50000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-110252000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97989000
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
454000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
281000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5946000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2392000
CY2019Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
523000
CY2019Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
112000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3713000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4381000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11249000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12801000
CY2019Q3 us-gaap Restricted Cash
RestrictedCash
CY2019Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
1
us-gaap Share Based Compensation
ShareBasedCompensation
490000
us-gaap Share Based Compensation
ShareBasedCompensation
387000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1600000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
200650
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
351428
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
204020
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
212731
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1413590
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.55
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.59
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
865163
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1862002
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.13
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.15
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.15
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.77
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.76
CY2019Q3 us-gaap Short Term Lease Commitment Amount
ShortTermLeaseCommitmentAmount
0
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
11000
us-gaap Stock Issued1
StockIssued1
us-gaap Stock Issued1
StockIssued1
31768000
CY2019Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1200000
CY2018Q1 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
7100000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
31768000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
35577000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2440000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
18903000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
11238000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
15845000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
22353000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
15988000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-38722000
CY2019Q3 us-gaap Sublease Income
SubleaseIncome
53000
us-gaap Sublease Income
SubleaseIncome
162000
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of Estimates</div>&nbsp;&#x2013;&nbsp;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities in the financial statements and accompanying notes. Actual results and outcomes could differ from these estimates and assumptions.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
44000
us-gaap Variable Lease Cost
VariableLeaseCost
132000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16249032
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7141189
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12748665
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6038001
CY2019Q3 vxrt Accrued Clinical And Manufacturing Expenses Current
AccruedClinicalAndManufacturingExpensesCurrent
7000
CY2018Q4 vxrt Accrued Clinical And Manufacturing Expenses Current
AccruedClinicalAndManufacturingExpensesCurrent
75000
CY2019Q3 vxrt Business Combination Bargain Purchase Gain Loss Recognized Amount
BusinessCombinationBargainPurchaseGainLossRecognizedAmount
CY2018Q3 vxrt Business Combination Bargain Purchase Gain Loss Recognized Amount
BusinessCombinationBargainPurchaseGainLossRecognizedAmount
vxrt Business Combination Bargain Purchase Gain Loss Recognized Amount
BusinessCombinationBargainPurchaseGainLossRecognizedAmount
vxrt Business Combination Bargain Purchase Gain Loss Recognized Amount
BusinessCombinationBargainPurchaseGainLossRecognizedAmount
6660000
CY2019Q2 vxrt Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2019Q3 vxrt Contract With Customer Asset Revenue Recognized
ContractWithCustomerAssetRevenueRecognized
0
CY2018Q4 vxrt Contract With Customer Asset Revenue Recognized
ContractWithCustomerAssetRevenueRecognized
0
CY2018Q1 vxrt Exchange Ratio Number Of Shares Exchanged Per Share
ExchangeRatioNumberOfSharesExchangedPerShare
0.0201346
CY2019Q1 vxrt Gross Proceeds From Issuance Of Common Stock
GrossProceedsFromIssuanceOfCommonStock
3000000
vxrt Impairment Of Property And Equipment
ImpairmentOfPropertyAndEquipment
106000
CY2019Q3 vxrt Impairment Of Property And Equipment
ImpairmentOfPropertyAndEquipment
CY2018Q3 vxrt Impairment Of Property And Equipment
ImpairmentOfPropertyAndEquipment
106000
vxrt Impairment Of Property And Equipment
ImpairmentOfPropertyAndEquipment
vxrt Issuance Of Warrants To Placement Agents Designees
IssuanceOfWarrantsToPlacementAgentsDesignees
100000
vxrt Issuance Of Warrants To Placement Agents Designees
IssuanceOfWarrantsToPlacementAgentsDesignees
vxrt Issuance Of Warrants To Underwriters Designees
IssuanceOfWarrantsToUnderwritersDesignees
830000
vxrt Issuance Of Warrants To Underwriters Designees
IssuanceOfWarrantsToUnderwritersDesignees
CY2019Q3 vxrt Lessee Finance Lease Number Of Leases
LesseeFinanceLeaseNumberOfLeases
0
CY2019Q3 vxrt Lessee Operating Lease Number Leases Exceeding Less Than One Year
LesseeOperatingLeaseNumberLeasesExceedingLessThanOneYear
3
CY2019Q3 vxrt Lessee Operating Lease Number Leases Exceeding One Year
LesseeOperatingLeaseNumberLeasesExceedingOneYear
3
CY2019Q3 vxrt Lessee Operating Lease Number Of Leases
LesseeOperatingLeaseNumberOfLeases
5
CY2019Q3 vxrt Lessee Operating Lease Number Of Rightofuse Leases Subleased
LesseeOperatingLeaseNumberOfRightofuseLeasesSubleased
1
CY2019Q3 vxrt Liability Related To Sale Of Future Royalties Current
LiabilityRelatedToSaleOfFutureRoyaltiesCurrent
3228000
CY2018Q4 vxrt Liability Related To Sale Of Future Royalties Current
LiabilityRelatedToSaleOfFutureRoyaltiesCurrent
3328000
CY2019Q3 vxrt Liability Related To Sale Of Future Royalties Noncurrent
LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent
12926000
CY2018Q4 vxrt Liability Related To Sale Of Future Royalties Noncurrent
LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent
14413000
CY2019Q3 vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
500000
CY2018Q3 vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
532000
vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
1560000
vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
1298000
vxrt Noncash Revenue Related To Sale Of Future Royalties
NoncashRevenueRelatedToSaleOfFutureRoyalties
3147000
vxrt Noncash Revenue Related To Sale Of Future Royalties
NoncashRevenueRelatedToSaleOfFutureRoyalties
18000
CY2019Q2 vxrt Payments For Aggregate Commissions To Underwriters
PaymentsForAggregateCommissionsToUnderwriters
750000
vxrt Reclassification Of Convertible Preferred Stock Warrant Liability To Equity
ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity
vxrt Reclassification Of Convertible Preferred Stock Warrant Liability To Equity
ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity
70000
CY2019Q3 vxrt Reserve For Return Of Royalties Current
ReserveForReturnOfRoyaltiesCurrent
178000
CY2018Q4 vxrt Reserve For Return Of Royalties Current
ReserveForReturnOfRoyaltiesCurrent
339000
CY2019Q3 vxrt Revenue Remaining Performance Obligation Not Recorded On Balance Sheet
RevenueRemainingPerformanceObligationNotRecordedOnBalanceSheet
413000
CY2019Q3 vxrt Secured Promissory Note Classified Current
SecuredPromissoryNoteClassifiedCurrent
2454000
CY2018Q4 vxrt Secured Promissory Note Classified Current
SecuredPromissoryNoteClassifiedCurrent
1667000
CY2019Q3 vxrt Secured Promissory Note Classified Noncurrent
SecuredPromissoryNoteClassifiedNoncurrent
CY2018Q4 vxrt Secured Promissory Note Classified Noncurrent
SecuredPromissoryNoteClassifiedNoncurrent
1944000
vxrt Share Based Compensation Arrangement By Share Based Payment Award Canceled
ShareBasedCompensationArrangementByShareBasedPaymentAwardCanceled
22739
vxrt Share Based Compensation Arrangement By Share Based Payment Award Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeited
165018
vxrt Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Removed From Plan
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesRemovedFromPlan
223389
vxrt Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant Decrease From Grants
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantDecreaseFromGrants
1413590
vxrt Stock Issued During Period Value Conversion Of Preferred Stock
StockIssuedDuringPeriodValueConversionOfPreferredStock
CY2019Q3 vxrt Stock Issued During Period Value Exercise Of Pre Funded Warrants
StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
431000
vxrt Stock Issued During Period Value Exercise Of Pre Funded Warrants
StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
1083000
CY2018Q4 vxrt Stockholders Equity Adjusted Balance
StockholdersEquityAdjustedBalance
11211000

Files In Submission

Name View Source Status
0001437749-19-022502-index-headers.html Edgar Link pending
0001437749-19-022502-index.html Edgar Link pending
0001437749-19-022502.txt Edgar Link pending
0001437749-19-022502-xbrl.zip Edgar Link pending
ex_156054.htm Edgar Link pending
ex_156055.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pipelineqthird.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vxrt-20190930.xml Edgar Link completed
vxrt-20190930.xsd Edgar Link pending
vxrt-20190930_cal.xml Edgar Link unprocessable
vxrt-20190930_def.xml Edgar Link unprocessable
vxrt-20190930_lab.xml Edgar Link unprocessable
vxrt-20190930_pre.xml Edgar Link unprocessable
vxrt20190930_10q.htm Edgar Link pending